FDA Uncertainty and Cosmetics Labeling: How to Prepare Without a Deadline
If the FDA published the fragrance allergen rule tomorrow morning, how long would it take you to update every affected label? Not to work out which ones are affected. To actually change them, route them for approval, and get them to print.
Most people we put that question to can't answer it, because the question has simply never needed answering before, because regulators used to arrive with a date attached, and a date lets you build a plan around it.
Right now though? There's no date and there's barely an agency to ask either, so you’d be forgiven for feeling a little stressed and uncertain if you work in the cosmetics space right now.
What FDA Leadership Changes Mean for Cosmetics Brands
We speak to regulatory and packaging teams across the sector regularly, and the tone has shifted noticeably this year. People aren't confused about what's coming – they've read the same information as everyone else. Instead, they’re stuck waiting to see when that set of obligations will land eventually, on a schedule set by an agency in the middle of its own upheaval, hitting product ranges that in some cases run to thousands of SKUs.
We’ve heard it described as packing for a trip without knowing the destination or the departure date. You know you'll need to move fast, but you just can't do anything with that knowledge yet.
Why Delayed Regulations Increase Labeling Workload and Risk
Delay often feels like relief, like the pressure is off and you can take a step back. In actual fact, it’s the complete opposite.
Every month a rule sits unpublished, the eventual compliance window doesn't get longer. It gets denser. The work doesn't evaporate during the wait. Instead it accumulates, then arrives in a single lump, competing with the launches, seasonal packs, and market variants already sitting in your queue.
So the thing worth focusing on isn't the date. It's the lag: the number of days between a rule landing and your last affected label being approved and out the door.
That number belongs entirely to you. It's determined by how your labeling operation is built, and unlike the FDA's timetable, you could change it – and it’s probably quicker and easier than you think!
What Slows Down Cosmetics Label and Artwork Updates
The thing slowing down cosmetic label and artwork updates is rarely the change itself, but rather finding the change and making it accurately. When label content lives inside artwork files, every ingredient statement is a separate object. Update one allergen declaration across 800 SKUs and you're opening 800 files. Answering "which of our products contain this?" becomes a manual audit rather than a search.
Then there's sign-off. Approval routed through email and shared drives is slow at normal volumes and falls over at high ones. Version control gets fuzzy, people chase, and eventually someone approves the wrong proof. Structured artwork approval fixes this by making the route itself the record, so the audit trail builds as people work rather than being reconstructed from inboxes six months later.
Cloud-based label and artwork systems matter more here than they might sound like they should. Regulatory work is distributed now. A supplier in one country, a reviewer in another, a print partner somewhere else again. Everyone needs the current version, not a current version.
Put those pieces together and the shape of the problem changes. Label content becomes reusable components rather than text welded into a file. One approved change flows through to every product that uses it. Where-used search returns the affected list in seconds instead of weeks. A regulatory update stops being an event and becomes a task.
Is Labeling Software Worth the Investment?
We get it, managing emails and spreadsheets is practically free, whereas investing in software can be costly. It’s true, enterprise labeling software is a real investment and the payback doesn’t happen immediately.
But look at what the alternative really costs. We’re talking about the hours spent hunting SKUs, the rework when an outdated ingredient list reaches print, and the launches held up because artwork is stuck behind a compliance scramble. Nevermind the reputational, monetary and even life-threatening consequences of a recall! Reality is, those costs are being paid by your business right now, just spread thinly enough that nobody puts them on a line item. And the volume of regulatory change heading toward this sector isn't going to make them smaller.
Moving Legacy Labels Into a New System Without the Pain
If cost isn’t your objection to making the move, we can almost bet the migration process is what’s holding you back. Nobody wants to hand over a decade of legacy artwork and hope it comes out the other side intact.
If that's the thing holding you back, it's worth knowing our platform uses a migration tool called AToM to handle exactly this. It reads your existing labels and artwork and converts them into structured, reusable content, which turns onboarding from a multi-year manual slog into something considerably shorter and a great deal less painful.
Preparing for FDA Changes Without a Deadline
Here's the short version of all this. The uncertainty is real, and it isn't going away soon. But the reality is, setting the regulation date was never the part you controlled. What you control is what happens the day after it's announced. Whether that day means a room full of people opening artwork files one at a time, or a where-used search, one approved change, and a normal week.
That difference isn't down to how well your team knows the regulations. It's down to whether your label content is structured, your approvals are traceable, and your system is accessible to everyone who needs it. Get those three things right and regulatory change stops being an emergency.
The teams that will handle the next FDA announcement calmly are already making that change now, while there's no deadline forcing them to. That's the advantage of the current lull. You can't control when the FDA moves, but you can control whether that day is a scramble or just a Tuesday.
If you’re ready to make the move and transform your label and artwork management for the better, speak to one of our experts. Call us on +44 (0) 1827 318100, email enquiries@kallik.com, or fill in a form here.
Frequently asked questions
What is happening with FDA leadership?
Commissioner Marty Makary resigned in May 2026, prompting a series of senior departures across the agency. Kyle Diamantas has been serving as acting commissioner since. In August 2026, Dr. Heidi Overton was nominated as the next commissioner, subject to Senate confirmation. Separately, the FDA's Office of Cosmetics and Colors moved out of the Center for Food Safety and Applied Nutrition into the Office of the Chief Scientist in 2024.
Which FDA cosmetics rules are still pending?
Final rules on Good Manufacturing Practice, fragrance allergen disclosure, and standardized talc testing methods are all still outstanding, along with the FDA's assessment of PFAS in cosmetics. Fragrance allergen disclosure is the one most likely to require widespread label changes, since it is expected to affect ingredient statements across large portions of a product range.
Do FDA delays give cosmetics companies more time to prepare?
Not in practice. A delayed rule does not extend the compliance window once it is published, it simply concentrates the work into a shorter period. The label changes still have to happen, but they arrive as a single block of work competing with launches, seasonal packs, and market variants already in the queue.
How long does it take to update labels across thousands of SKUs?
It depends entirely on how label content is stored. Where content sits inside individual artwork files, each affected SKU has to be identified and edited separately, which can take weeks or months. Where content is managed as reusable components, a where-used search identifies affected products in seconds and a single approved change flows through to all of them.
How can cosmetics companies prepare for FDA rules that have no deadline?
Focus on the lag rather than the date. That means the number of days between a rule being published and every affected label being updated, approved, and sent to print. Structuring label content, making approval routes traceable, and moving to a cloud-based system all reduce that number, and none of them require knowing when the rule lands.